The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Famciclovir API Market Research Report 2025
Synopsis
Famciclovir is a guanosine analogue antiviral drug used for the treatment of various herpesvirus infections, most commonly for herpes zoster (shingles). It is a prodrug form of penciclovir with improved oral bioavailability. Famciclovir is marketed under the trade name Famvir (Novartis)
The global Famciclovir API market was valued at US$ 13 million in 2023 and is anticipated to reach US$ 15 million by 2030, witnessing a CAGR of 2.3% during the forecast period 2024-2030.
The classification of Famciclovir API includes Insourced and Outsourced. In addition, the proportion of Insulin Outsourced in 2019 is about 71%, and the proportion is in increasing trend from 2015 to 2020.
Famciclovir API is widely used in Tablet Product, Capsule Product and Others Product. The most proportion of Famciclovir API is used in Tablet Product, and the proportion in 2019 is about 80%.
Asia-Pacific is the largest consumption market, with a market share nearly 48% in 2019. Following Asia-Pacific, North America is the second largest consumption market with the market share of about 21%.
Market competition is intense. Chongqing Shenghuaxi Pharma, Aurobindo Pharma Limited, Apotex Pharmachem, Changzhou Kony Pharma Co, Teva Pharmaceutical Industries, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
This report aims to provide a comprehensive presentation of the global market for Famciclovir API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Famciclovir API.
Report Scope
The Famciclovir API market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Famciclovir API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Famciclovir API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Chongqing Shenghuaxi Pharma
Aurobindo Pharma Limited
Apotex Pharmachem
Changzhou Kony Pharma Co
Teva Pharmaceutical Industries
Olon
Fuan Pharmaceutical
Zhejiang Charioteer Pharmaceutical
Jialin Pharmaceutical
Zhejiang Hisun
Hetero
Segment by Type
Insourced
Outsourced
Others
Segment by Application
Tablet Product
Capsule Product
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Famciclovir API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Famciclovir API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Famciclovir is a guanosine analogue antiviral drug used for the treatment of various herpesvirus infections, most commonly for herpes zoster (shingles). It is a prodrug form of penciclovir with improved oral bioavailability. Famciclovir is marketed under the trade name Famvir (Novartis)
The global Famciclovir API market was valued at US$ 13 million in 2023 and is anticipated to reach US$ 15 million by 2030, witnessing a CAGR of 2.3% during the forecast period 2024-2030.
The classification of Famciclovir API includes Insourced and Outsourced. In addition, the proportion of Insulin Outsourced in 2019 is about 71%, and the proportion is in increasing trend from 2015 to 2020.
Famciclovir API is widely used in Tablet Product, Capsule Product and Others Product. The most proportion of Famciclovir API is used in Tablet Product, and the proportion in 2019 is about 80%.
Asia-Pacific is the largest consumption market, with a market share nearly 48% in 2019. Following Asia-Pacific, North America is the second largest consumption market with the market share of about 21%.
Market competition is intense. Chongqing Shenghuaxi Pharma, Aurobindo Pharma Limited, Apotex Pharmachem, Changzhou Kony Pharma Co, Teva Pharmaceutical Industries, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
This report aims to provide a comprehensive presentation of the global market for Famciclovir API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Famciclovir API.
Report Scope
The Famciclovir API market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Famciclovir API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Famciclovir API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Chongqing Shenghuaxi Pharma
Aurobindo Pharma Limited
Apotex Pharmachem
Changzhou Kony Pharma Co
Teva Pharmaceutical Industries
Olon
Fuan Pharmaceutical
Zhejiang Charioteer Pharmaceutical
Jialin Pharmaceutical
Zhejiang Hisun
Hetero
Segment by Type
Insourced
Outsourced
Others
Segment by Application
Tablet Product
Capsule Product
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Famciclovir API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Famciclovir API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Famciclovir API Market Overview
1.1 Product Overview and Scope of Famciclovir API
1.2 Famciclovir API Segment by Type
1.2.1 Global Famciclovir API Market Value Comparison by Type (2024-2030)
1.2.2 Insourced
1.2.3 Outsourced
1.2.4 Others
1.3 Famciclovir API Segment by Application
1.3.1 Global Famciclovir API Market Value by Application: (2024-2030)
1.3.2 Tablet Product
1.3.3 Capsule Product
1.3.4 Others
1.4 Global Famciclovir API Market Size Estimates and Forecasts
1.4.1 Global Famciclovir API Revenue 2019-2030
1.4.2 Global Famciclovir API Sales 2019-2030
1.4.3 Global Famciclovir API Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Famciclovir API Market Competition by Manufacturers
2.1 Global Famciclovir API Sales Market Share by Manufacturers (2019-2024)
2.2 Global Famciclovir API Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Famciclovir API Average Price by Manufacturers (2019-2024)
2.4 Global Famciclovir API Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Famciclovir API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Famciclovir API, Product Type & Application
2.7 Famciclovir API Market Competitive Situation and Trends
2.7.1 Famciclovir API Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Famciclovir API Players Market Share by Revenue
2.7.3 Global Famciclovir API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Famciclovir API Retrospective Market Scenario by Region
3.1 Global Famciclovir API Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Famciclovir API Global Famciclovir API Sales by Region: 2019-2030
3.2.1 Global Famciclovir API Sales by Region: 2019-2024
3.2.2 Global Famciclovir API Sales by Region: 2025-2030
3.3 Global Famciclovir API Global Famciclovir API Revenue by Region: 2019-2030
3.3.1 Global Famciclovir API Revenue by Region: 2019-2024
3.3.2 Global Famciclovir API Revenue by Region: 2025-2030
3.4 North America Famciclovir API Market Facts & Figures by Country
3.4.1 North America Famciclovir API Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Famciclovir API Sales by Country (2019-2030)
3.4.3 North America Famciclovir API Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Famciclovir API Market Facts & Figures by Country
3.5.1 Europe Famciclovir API Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Famciclovir API Sales by Country (2019-2030)
3.5.3 Europe Famciclovir API Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Famciclovir API Market Facts & Figures by Country
3.6.1 Asia Pacific Famciclovir API Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Famciclovir API Sales by Country (2019-2030)
3.6.3 Asia Pacific Famciclovir API Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Famciclovir API Market Facts & Figures by Country
3.7.1 Latin America Famciclovir API Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Famciclovir API Sales by Country (2019-2030)
3.7.3 Latin America Famciclovir API Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Famciclovir API Market Facts & Figures by Country
3.8.1 Middle East and Africa Famciclovir API Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Famciclovir API Sales by Country (2019-2030)
3.8.3 Middle East and Africa Famciclovir API Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Famciclovir API Sales by Type (2019-2030)
4.1.1 Global Famciclovir API Sales by Type (2019-2024)
4.1.2 Global Famciclovir API Sales by Type (2025-2030)
4.1.3 Global Famciclovir API Sales Market Share by Type (2019-2030)
4.2 Global Famciclovir API Revenue by Type (2019-2030)
4.2.1 Global Famciclovir API Revenue by Type (2019-2024)
4.2.2 Global Famciclovir API Revenue by Type (2025-2030)
4.2.3 Global Famciclovir API Revenue Market Share by Type (2019-2030)
4.3 Global Famciclovir API Price by Type (2019-2030)
5 Segment by Application
5.1 Global Famciclovir API Sales by Application (2019-2030)
5.1.1 Global Famciclovir API Sales by Application (2019-2024)
5.1.2 Global Famciclovir API Sales by Application (2025-2030)
5.1.3 Global Famciclovir API Sales Market Share by Application (2019-2030)
5.2 Global Famciclovir API Revenue by Application (2019-2030)
5.2.1 Global Famciclovir API Revenue by Application (2019-2024)
5.2.2 Global Famciclovir API Revenue by Application (2025-2030)
5.2.3 Global Famciclovir API Revenue Market Share by Application (2019-2030)
5.3 Global Famciclovir API Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Chongqing Shenghuaxi Pharma
6.1.1 Chongqing Shenghuaxi Pharma Corporation Information
6.1.2 Chongqing Shenghuaxi Pharma Description and Business Overview
6.1.3 Chongqing Shenghuaxi Pharma Famciclovir API Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Chongqing Shenghuaxi Pharma Famciclovir API Product Portfolio
6.1.5 Chongqing Shenghuaxi Pharma Recent Developments/Updates
6.2 Aurobindo Pharma Limited
6.2.1 Aurobindo Pharma Limited Corporation Information
6.2.2 Aurobindo Pharma Limited Description and Business Overview
6.2.3 Aurobindo Pharma Limited Famciclovir API Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Aurobindo Pharma Limited Famciclovir API Product Portfolio
6.2.5 Aurobindo Pharma Limited Recent Developments/Updates
6.3 Apotex Pharmachem
6.3.1 Apotex Pharmachem Corporation Information
6.3.2 Apotex Pharmachem Description and Business Overview
6.3.3 Apotex Pharmachem Famciclovir API Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Apotex Pharmachem Famciclovir API Product Portfolio
6.3.5 Apotex Pharmachem Recent Developments/Updates
6.4 Changzhou Kony Pharma Co
6.4.1 Changzhou Kony Pharma Co Corporation Information
6.4.2 Changzhou Kony Pharma Co Description and Business Overview
6.4.3 Changzhou Kony Pharma Co Famciclovir API Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Changzhou Kony Pharma Co Famciclovir API Product Portfolio
6.4.5 Changzhou Kony Pharma Co Recent Developments/Updates
6.5 Teva Pharmaceutical Industries
6.5.1 Teva Pharmaceutical Industries Corporation Information
6.5.2 Teva Pharmaceutical Industries Description and Business Overview
6.5.3 Teva Pharmaceutical Industries Famciclovir API Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Teva Pharmaceutical Industries Famciclovir API Product Portfolio
6.5.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.6 Olon
6.6.1 Olon Corporation Information
6.6.2 Olon Description and Business Overview
6.6.3 Olon Famciclovir API Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Olon Famciclovir API Product Portfolio
6.6.5 Olon Recent Developments/Updates
6.7 Fuan Pharmaceutical
6.6.1 Fuan Pharmaceutical Corporation Information
6.6.2 Fuan Pharmaceutical Description and Business Overview
6.6.3 Fuan Pharmaceutical Famciclovir API Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Fuan Pharmaceutical Famciclovir API Product Portfolio
6.7.5 Fuan Pharmaceutical Recent Developments/Updates
6.8 Zhejiang Charioteer Pharmaceutical
6.8.1 Zhejiang Charioteer Pharmaceutical Corporation Information
6.8.2 Zhejiang Charioteer Pharmaceutical Description and Business Overview
6.8.3 Zhejiang Charioteer Pharmaceutical Famciclovir API Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Zhejiang Charioteer Pharmaceutical Famciclovir API Product Portfolio
6.8.5 Zhejiang Charioteer Pharmaceutical Recent Developments/Updates
6.9 Jialin Pharmaceutical
6.9.1 Jialin Pharmaceutical Corporation Information
6.9.2 Jialin Pharmaceutical Description and Business Overview
6.9.3 Jialin Pharmaceutical Famciclovir API Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Jialin Pharmaceutical Famciclovir API Product Portfolio
6.9.5 Jialin Pharmaceutical Recent Developments/Updates
6.10 Zhejiang Hisun
6.10.1 Zhejiang Hisun Corporation Information
6.10.2 Zhejiang Hisun Description and Business Overview
6.10.3 Zhejiang Hisun Famciclovir API Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Zhejiang Hisun Famciclovir API Product Portfolio
6.10.5 Zhejiang Hisun Recent Developments/Updates
6.11 Hetero
6.11.1 Hetero Corporation Information
6.11.2 Hetero Famciclovir API Description and Business Overview
6.11.3 Hetero Famciclovir API Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hetero Famciclovir API Product Portfolio
6.11.5 Hetero Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Famciclovir API Industry Chain Analysis
7.2 Famciclovir API Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Famciclovir API Production Mode & Process
7.4 Famciclovir API Sales and Marketing
7.4.1 Famciclovir API Sales Channels
7.4.2 Famciclovir API Distributors
7.5 Famciclovir API Customers
8 Famciclovir API Market Dynamics
8.1 Famciclovir API Industry Trends
8.2 Famciclovir API Market Drivers
8.3 Famciclovir API Market Challenges
8.4 Famciclovir API Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Famciclovir API Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Famciclovir API Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Famciclovir API Market Competitive Situation by Manufacturers in 2023
Table 4. Global Famciclovir API Sales (KG) of Key Manufacturers (2019-2024)
Table 5. Global Famciclovir API Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Famciclovir API Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Famciclovir API Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Famciclovir API Average Price (US$/KG) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Famciclovir API, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Famciclovir API, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Famciclovir API, Product Type & Application
Table 12. Global Key Manufacturers of Famciclovir API, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Famciclovir API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Famciclovir API as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Famciclovir API Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Famciclovir API Sales by Region (2019-2024) & (KG)
Table 18. Global Famciclovir API Sales Market Share by Region (2019-2024)
Table 19. Global Famciclovir API Sales by Region (2025-2030) & (KG)
Table 20. Global Famciclovir API Sales Market Share by Region (2025-2030)
Table 21. Global Famciclovir API Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Famciclovir API Revenue Market Share by Region (2019-2024)
Table 23. Global Famciclovir API Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Famciclovir API Revenue Market Share by Region (2025-2030)
Table 25. North America Famciclovir API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Famciclovir API Sales by Country (2019-2024) & (KG)
Table 27. North America Famciclovir API Sales by Country (2025-2030) & (KG)
Table 28. North America Famciclovir API Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Famciclovir API Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Famciclovir API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Famciclovir API Sales by Country (2019-2024) & (KG)
Table 32. Europe Famciclovir API Sales by Country (2025-2030) & (KG)
Table 33. Europe Famciclovir API Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Famciclovir API Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Famciclovir API Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Famciclovir API Sales by Region (2019-2024) & (KG)
Table 37. Asia Pacific Famciclovir API Sales by Region (2025-2030) & (KG)
Table 38. Asia Pacific Famciclovir API Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Famciclovir API Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Famciclovir API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Famciclovir API Sales by Country (2019-2024) & (KG)
Table 42. Latin America Famciclovir API Sales by Country (2025-2030) & (KG)
Table 43. Latin America Famciclovir API Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Famciclovir API Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Famciclovir API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Famciclovir API Sales by Country (2019-2024) & (KG)
Table 47. Middle East & Africa Famciclovir API Sales by Country (2025-2030) & (KG)
Table 48. Middle East & Africa Famciclovir API Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Famciclovir API Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Famciclovir API Sales (KG) by Type (2019-2024)
Table 51. Global Famciclovir API Sales (KG) by Type (2025-2030)
Table 52. Global Famciclovir API Sales Market Share by Type (2019-2024)
Table 53. Global Famciclovir API Sales Market Share by Type (2025-2030)
Table 54. Global Famciclovir API Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Famciclovir API Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Famciclovir API Revenue Market Share by Type (2019-2024)
Table 57. Global Famciclovir API Revenue Market Share by Type (2025-2030)
Table 58. Global Famciclovir API Price (US$/KG) by Type (2019-2024)
Table 59. Global Famciclovir API Price (US$/KG) by Type (2025-2030)
Table 60. Global Famciclovir API Sales (KG) by Application (2019-2024)
Table 61. Global Famciclovir API Sales (KG) by Application (2025-2030)
Table 62. Global Famciclovir API Sales Market Share by Application (2019-2024)
Table 63. Global Famciclovir API Sales Market Share by Application (2025-2030)
Table 64. Global Famciclovir API Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Famciclovir API Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Famciclovir API Revenue Market Share by Application (2019-2024)
Table 67. Global Famciclovir API Revenue Market Share by Application (2025-2030)
Table 68. Global Famciclovir API Price (US$/KG) by Application (2019-2024)
Table 69. Global Famciclovir API Price (US$/KG) by Application (2025-2030)
Table 70. Chongqing Shenghuaxi Pharma Corporation Information
Table 71. Chongqing Shenghuaxi Pharma Description and Business Overview
Table 72. Chongqing Shenghuaxi Pharma Famciclovir API Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
Table 73. Chongqing Shenghuaxi Pharma Famciclovir API Product
Table 74. Chongqing Shenghuaxi Pharma Recent Developments/Updates
Table 75. Aurobindo Pharma Limited Corporation Information
Table 76. Aurobindo Pharma Limited Description and Business Overview
Table 77. Aurobindo Pharma Limited Famciclovir API Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
Table 78. Aurobindo Pharma Limited Famciclovir API Product
Table 79. Aurobindo Pharma Limited Recent Developments/Updates
Table 80. Apotex Pharmachem Corporation Information
Table 81. Apotex Pharmachem Description and Business Overview
Table 82. Apotex Pharmachem Famciclovir API Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
Table 83. Apotex Pharmachem Famciclovir API Product
Table 84. Apotex Pharmachem Recent Developments/Updates
Table 85. Changzhou Kony Pharma Co Corporation Information
Table 86. Changzhou Kony Pharma Co Description and Business Overview
Table 87. Changzhou Kony Pharma Co Famciclovir API Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
Table 88. Changzhou Kony Pharma Co Famciclovir API Product
Table 89. Changzhou Kony Pharma Co Recent Developments/Updates
Table 90. Teva Pharmaceutical Industries Corporation Information
Table 91. Teva Pharmaceutical Industries Description and Business Overview
Table 92. Teva Pharmaceutical Industries Famciclovir API Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
Table 93. Teva Pharmaceutical Industries Famciclovir API Product
Table 94. Teva Pharmaceutical Industries Recent Developments/Updates
Table 95. Olon Corporation Information
Table 96. Olon Description and Business Overview
Table 97. Olon Famciclovir API Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
Table 98. Olon Famciclovir API Product
Table 99. Olon Recent Developments/Updates
Table 100. Fuan Pharmaceutical Corporation Information
Table 101. Fuan Pharmaceutical Description and Business Overview
Table 102. Fuan Pharmaceutical Famciclovir API Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
Table 103. Fuan Pharmaceutical Famciclovir API Product
Table 104. Fuan Pharmaceutical Recent Developments/Updates
Table 105. Zhejiang Charioteer Pharmaceutical Corporation Information
Table 106. Zhejiang Charioteer Pharmaceutical Description and Business Overview
Table 107. Zhejiang Charioteer Pharmaceutical Famciclovir API Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
Table 108. Zhejiang Charioteer Pharmaceutical Famciclovir API Product
Table 109. Zhejiang Charioteer Pharmaceutical Recent Developments/Updates
Table 110. Jialin Pharmaceutical Corporation Information
Table 111. Jialin Pharmaceutical Description and Business Overview
Table 112. Jialin Pharmaceutical Famciclovir API Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
Table 113. Jialin Pharmaceutical Famciclovir API Product
Table 114. Jialin Pharmaceutical Recent Developments/Updates
Table 115. Zhejiang Hisun Corporation Information
Table 116. Zhejiang Hisun Description and Business Overview
Table 117. Zhejiang Hisun Famciclovir API Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
Table 118. Zhejiang Hisun Famciclovir API Product
Table 119. Zhejiang Hisun Recent Developments/Updates
Table 120. Hetero Corporation Information
Table 121. Hetero Description and Business Overview
Table 122. Hetero Famciclovir API Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2019-2024)
Table 123. Hetero Famciclovir API Product
Table 124. Hetero Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Famciclovir API Distributors List
Table 128. Famciclovir API Customers List
Table 129. Famciclovir API Market Trends
Table 130. Famciclovir API Market Drivers
Table 131. Famciclovir API Market Challenges
Table 132. Famciclovir API Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Famciclovir API
Figure 2. Global Famciclovir API Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Famciclovir API Market Share by Type in 2023 & 2030
Figure 4. Insourced Product Picture
Figure 5. Outsourced Product Picture
Figure 6. Others Product Picture
Figure 7. Global Famciclovir API Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Famciclovir API Market Share by Application in 2023 & 2030
Figure 9. Tablet Product
Figure 10. Capsule Product
Figure 11. Others
Figure 12. Global Famciclovir API Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Famciclovir API Market Size (2019-2030) & (US$ Million)
Figure 14. Global Famciclovir API Sales (2019-2030) & (KG)
Figure 15. Global Famciclovir API Average Price (US$/KG) & (2019-2030)
Figure 16. Famciclovir API Report Years Considered
Figure 17. Famciclovir API Sales Share by Manufacturers in 2023
Figure 18. Global Famciclovir API Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Famciclovir API Players: Market Share by Revenue in 2023
Figure 20. Famciclovir API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Famciclovir API Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Famciclovir API Sales Market Share by Country (2019-2030)
Figure 23. North America Famciclovir API Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Famciclovir API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Famciclovir API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Famciclovir API Sales Market Share by Country (2019-2030)
Figure 27. Europe Famciclovir API Revenue Market Share by Country (2019-2030)
Figure 28. Germany Famciclovir API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Famciclovir API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Famciclovir API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Famciclovir API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Famciclovir API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Famciclovir API Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Famciclovir API Revenue Market Share by Region (2019-2030)
Figure 35. China Famciclovir API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Famciclovir API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Famciclovir API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Famciclovir API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Famciclovir API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Famciclovir API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Famciclovir API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Famciclovir API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Famciclovir API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Famciclovir API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Famciclovir API Sales Market Share by Country (2019-2030)
Figure 46. Latin America Famciclovir API Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Famciclovir API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Famciclovir API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Famciclovir API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Famciclovir API Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Famciclovir API Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Famciclovir API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Famciclovir API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Famciclovir API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Famciclovir API by Type (2019-2030)
Figure 56. Global Revenue Market Share of Famciclovir API by Type (2019-2030)
Figure 57. Global Famciclovir API Price (US$/KG) by Type (2019-2030)
Figure 58. Global Sales Market Share of Famciclovir API by Application (2019-2030)
Figure 59. Global Revenue Market Share of Famciclovir API by Application (2019-2030)
Figure 60. Global Famciclovir API Price (US$/KG) by Application (2019-2030)
Figure 61. Famciclovir API Value Chain
Figure 62. Famciclovir API Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
